초록접수 현황
| 15F-062 | 구연 발표 |
Mid-Term Result of Single Incisional Thoracoscopic Major Pulmonary Resection
한국남, 김현구, 이현주, 최영호
고려대학교 의과대학 구로병원 흉부외과학교실
Background : Initial thoracoscopic approach to early lung cancer has undergone major changes from three-port to single incisional approach in our center. We retrospectively evaluated the outcomes of single incisional surgery in primary lung malignancy to determine its safety and efficacy.
Methods : A retrospective data of 247 patients who underwent single incisional VATS (SIVATS) major lung resection between November 2012 and June 2015 was analyzed. Patient characteristics, perioperative outcomes, pathologic result, and follow-up data were reviewed.
Results : Single incisional thoracoscopic major lung resection was performed in 247 patients for both lung malignancy and benign condition of the lung. 203 patients (82.2%) had NSCLC, 14 (5.7%) had secondary lung cancer, 6 (2.4%) had small cell lung cancer, 1 (0.4%) had other primary lung malignancy, and 23 (9.3%) had benign disease. Among the 203 NSCLC patients, they underwent 26 sublobar resection (12.8%) (18 segmentectomy and 8 wedge resection), 167 lobectomies (82.3%), 3 bilobectomy (1.5%), 4 sleeve resection (2%), and 3 pneumonectomies (1.5%). 11 patients (5.4%) need conversion to mini-thoracotomy (n=9) or multiport VATS (n=2). The operation time for lobectomy was mean 192.8 ± 63.3 min. 16 had undergone neoadjuvant chemotherapy, and finally 5 (2.5%) had regressed to ypT0N0. 156 (76.8%) were stage stage I, 29 (14.3%) were stage II, and 18 (8.9%) were stage III or greater. There were no intraoperative event and 19 major morbidities (9.4%) were developed (9 pneumonias, 5 atrial fibrillations, 4 respiratory failures, and 1 pulmonary embolism). There were 5 early mortalities (2.5%) (<30 day). The survival rate of stage I NSCLC were 95.7 % at 1-year and 94.4 % at 2-years.
Conclusion : Single incisional approach for VATS major lung resection for lung malignancy and benign lung disease could be benefit from low perioperative morbidity and mortality.
Methods : A retrospective data of 247 patients who underwent single incisional VATS (SIVATS) major lung resection between November 2012 and June 2015 was analyzed. Patient characteristics, perioperative outcomes, pathologic result, and follow-up data were reviewed.
Results : Single incisional thoracoscopic major lung resection was performed in 247 patients for both lung malignancy and benign condition of the lung. 203 patients (82.2%) had NSCLC, 14 (5.7%) had secondary lung cancer, 6 (2.4%) had small cell lung cancer, 1 (0.4%) had other primary lung malignancy, and 23 (9.3%) had benign disease. Among the 203 NSCLC patients, they underwent 26 sublobar resection (12.8%) (18 segmentectomy and 8 wedge resection), 167 lobectomies (82.3%), 3 bilobectomy (1.5%), 4 sleeve resection (2%), and 3 pneumonectomies (1.5%). 11 patients (5.4%) need conversion to mini-thoracotomy (n=9) or multiport VATS (n=2). The operation time for lobectomy was mean 192.8 ± 63.3 min. 16 had undergone neoadjuvant chemotherapy, and finally 5 (2.5%) had regressed to ypT0N0. 156 (76.8%) were stage stage I, 29 (14.3%) were stage II, and 18 (8.9%) were stage III or greater. There were no intraoperative event and 19 major morbidities (9.4%) were developed (9 pneumonias, 5 atrial fibrillations, 4 respiratory failures, and 1 pulmonary embolism). There were 5 early mortalities (2.5%) (<30 day). The survival rate of stage I NSCLC were 95.7 % at 1-year and 94.4 % at 2-years.
Conclusion : Single incisional approach for VATS major lung resection for lung malignancy and benign lung disease could be benefit from low perioperative morbidity and mortality.
책임저자: 김현구
고려대학교 의과대학 구로병원 흉부외과학교실
연락처 : 한국남, Tel: 010-4103-9290 , E-mail : hdoccomta@naver.com
